Neoadjuvant trabectedin may be an alternative to standard chemotherapy for patients with high-grade myxoid liposarcoma of the extremities or trunk, according to researchers.

Prophylaxis with tixagevimab and cilgavimab (Evusheld) reduced the risk of breakthrough SARS-CoV-2 infections and the severity of COVID-19 among patients with hematologic cancers in an Italian study.

Metabolic changes associated with progression-free survival in patients receiving pembrolizumab.

Researchers conducted a review of hospice care use to determine research outcomes and disparities among patients with cancer regarding its use.

Certain foods are associated with a lower risk of premature aging in adult survivors of childhood cancer, new research suggests.

Adding palbociclib to letrozole did not improve OS in postmenopausal patients with ER+, HER2- advanced breast cancer in the PALOMA-2 trial.

Radical prostatectomy linked to worse urinary incontinence but not worse sexual function for men with favorable, unfavorable prognosis.

This study compared the quality of content in YouTube videos on chemotherapy for pediatric patients from independent users with that of videos from official health institutions.

The sBLA submission was supported by data from the phase 2 DESTINY-PanTumor02 trial, which included adults with selected HER2-expressing tumors.

Obe-cel is an investigational autologous CAR T-cell therapy designed with a fast off-rate CD19 binder to reduce toxicity and increase long-term persistence.